Federal Register / Vol. 66, No. 111 / Friday, June 8, 2001 / Notices 30931

postmarked on or before the application

due date (listed for all areas in Table I).

A legibly dated receipt from a

commercial carrier or U.S. Postal

Service will be accepted in lieu of a

postmark. Private metered postmarks

will not be accepted as proof of timely

mailing. All hand delivered applications

must be received between the hours of

8:30 a.m. and 5 p.m. on or before the

application due date. Applications

which do not meet the deadline will be

considered late and will not be accepted

for review. Also, applications which do

not meet the requirements of this

program announcement and/or the

applicable regulatory requirements at 42

CFR part 59, Subpart A, will not be

accepted for review. Any application

which is not accepted will be returned

to the applicant. Applications will not

be accepted by fax or e-mail. The

submission deadlines will not be

extended.

Applications must address all

applicable regulatory requirements

[59.7(a)]. The information collections

(reporting requirements) contained in

this notice have been approved by the

Office of Management and Budget and

assigned control number 0937–0189.

The Office of Public Health and

Science (OPHS) requires all grant

recipients to provide a smoke-free

workplace and to promote the non-use

of all tobacco products. This is

consistent with the OPHS mission to

protect and advance the physical and

mental health of the American people.

Application Review and Evaluation

Each regional office is responsible for

evaluating applications and setting

funding levels according to criteria in 42

CFR 59.7.

Applications will be evaluated based

on the following criteria (42 CFR

59.7(a)):

(1) The degree to which the project

plan adequately provides for the

requirements set forth in the Title X

regulations (20 points);

(2) The extent to which family

planning services are needed locally (20

points);

(3) The number of patients, and, in

particular, the number of low-income

patients to be served (15 points);

(4) The adequacy of the applicant’s

facilities and staff (15 points);

(5) The capacity of the applicant to

make rapid and effective use of the

Federal assistance (10 points);

(6) The relative availability of nonFederal resources within the community

to be served and the degree to which

those resources are committed to the

project (10 points); and

(7) The relative need of the applicant

(10 points).

Review Under Executive Order 12372

Applicants under this announcement

are subject to the review requirements of

Executive Order 12372,

Intergovernmental Review of

Department of Health and Human

Services Programs and Activities, as

implemented by 45 CFR part 100. As

soon as possible, the applicant should

discuss the project with the State Single

Point of Contact (SPOC) for each State

to be served. The application kit

contains the currently available listing

of the SPOCs which have elected to be

informed of the submission of

applications. For those States not listed,

further inquiries regarding the review

process designed by their state should

be made to the Governor’s office of the

pertinent State. In order to be

considered, the Grants Management

Office must receive State Single Point of

Contact comments not later than 30

days prior to the grant funding date.

Grant Awards

When final funding decisions have

been made, each applicant will be

notified by letter of the outcome of its

application. Applicant projects selected

for funding will receive a Notice of

Grant Award, the official document

notifying an applicant that a project

application has been approved for

funding. This document specifies to the

grantee the amount of money awarded,

the purposes of the grant, the length of

the project period, and terms and

conditions of the grant award.

Grant projects are generally approved

for 3 to 5 years. An annual noncompetitive continuation application is

required to obtain continued support.

Application kits for non-competing

grants will automatically be sent to the

project director indicated on the Notice

of Grant Award. Continuation awards

are subject to factors such as the

availability of funds and satisfactory

progress of the project. In all cases,

continuation awards require a

determination by HHS that continued

funding is in the best interest of the

Federal Government.

Mireille B. Kanda,

Acting Director, Office of Population Affairs.

[FR Doc. 01–14457 Filed 6–7–01; 8:45 am]

BILLING CODE 4150–34–M

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

Centers for Disease Control and

Prevention

[Program Announcement 01117]

Controlling Asthma in American Cities

Project (CAACP); Notice of Availability

of Funds

A. Purpose

The Centers for Disease Control and

Prevention (CDC) announces the

availability of fiscal year (FY) 2001

funds for a cooperative agreement

program for Controlling Asthma in

American Cities Project (CAACP). This

program addresses the ‘‘Healthy People

2010’’ focus areas of Respiratory

Diseases, Environmental Health, and

Access to Quality Health Services.

The purpose of the CAACP is to

utilize past successes and other

innovative approaches to improve

overall asthma management in order to

decrease asthma-related morbidity

among children (0–18 years) in a

defined urban population with a large

and unmet asthma control need.

No research may be conducted as part

of this cooperative agreement.

B. Eligible Applicants

Applications may be submitted by

public and private nonprofit

organizations, or local chapters of

national advocacy associations that deal

primarily or largely with asthma. This

includes universities, hospitals, and city

or county public health departments. In

addition, applicants must have direct

access to the target population(s) and be

located in the community that will be

served by the proposed interventions.

To be an eligible applicant, the total

population of the communities to be

served must be between 300,000 and

700,000 people. Note: For a

metropolitan area of greater than

700,000 people, the population

requirement may be met by proposing to

work in selected communities within

the area. This information must be

submitted in the abstract of the

application. The documentation

accepted to verify eligibility may be

based on the most current census data

available. If this information is not

included, the application will be

determined as non-responsive and will

be returned to the applicant without

review.

Note: Title 2 of the United States Code,

Chapter 26, Section 1611 states that an

organization described in section 501(c)(4) of

the Internal Revenue Code of 1986 that

engages in lobbying activities is not eligible

to receive Federal funds constituting an

30932 Federal Register / Vol. 66, No. 111 / Friday, June 8, 2001 / Notices

award, grant, cooperative agreement,

contract, loan, or any other form.

C. Availability of Funds

Approximately $3,000,000 is available

in FY 2001 to fund approximately four

to six planning projects (Phase I). It is

expected that the average award will be

approximately $450,000, ranging from

$300,000 to $500,000.

Applications that request more than

the maximum level of funding

($500,000) will be determined nonresponsive to this announcement and

returned to the applicant.

It is expected that the awards will

begin on or about September 30, 2001,

and will be made for a 12-month budget

period within a project period of two

years. Funding estimates may change.

Depending on the availability of

funds, a new competitive

announcement, limited to Phase I

awardees, may be announced in the

future that will implement the

intervention activities. It is expected

that the number of Phase II

(Intervention) recipients awarded will

be approximately three.

Use of Funds

Budgeted funds may not be used to

fund asthma surveillance, except those

directly related to the evaluation of the

CAACP project.

Funding Preferences

Funding preference may include: (1)

geographic balance; (2) minority

populations with a disproportionate

asthma burden, and (3) a balance of

proposed intervention strategies.

D. Programmatic Interests

Intervention Ideas/Concepts

Decreasing asthma-related morbidity

in a defined population will require a

comprehensive and innovative

approach, based on current scientific

knowledge and an in-depth

understanding of the communities to be

focused upon, to improving asthma

medical care and self-care within

families with a child with asthma.

Intervention ideas should be based on

asthma care concepts which have been

analyzed through the peer-review

process and shown to be effective in

improving asthma control.

Collaboration

Success of the planning phase and

intervention phase of the proposed

project will depend heavily on the

ability of the grantee to form or work

through an effective consortium. The

applicant must have the experience,

ability, and vision to lead such an effort

through the active coordination and

participation of the most important and

influential health and health care

leaders in their communities.

E. Program Requirements

In conducting activities to achieve the

purpose of this program, the recipient

will be responsible for the activities

under 1. (Recipient Activities), and CDC

will be responsible for the activities

listed under 2. (CDC Activities).

1. Recipient Activities

a. Develop a plan that includes timephased intervention objectives,

protocols, relevant policy initiatives,

and evaluation plans that address the

asthma objective(s) in Healthy People

2010.

b. Collect baseline asthma data in the

communities to be served by the project.

The data should include measures of

asthma morbidity and actual asthma

care representative of the entire study

population before the intervention

phase begins.

c. Develop or enhance an asthma

consortium that includes, among others,

public, private, and academic partners

and community based organizations

(CBO’s) that can be sustained for

subsequent research and program

development.

d. Serve as a resource for other asthma

projects.

e. Disseminate relevant findings.

2. CDC Activities

a. Provide technical assistance, as

requested, in the development of

intervention protocols, evaluation plans,

communication issues, policy issues,

and the interpretation of the scientific

literature related to asthma management

and control.

b. Provide liaison among grantees and

potential sources of information and

assistance.

c. Coordinate activities among sites,

when appropriate.

d. Convene meetings among

collaborators to discuss findings and

improve outcomes.

F. Content

Letter of Intent

A one-page non-binding letter of

intent (LOI) is requested to enable CDC

to determine the level of interest in this

announcement. The LOI should provide

a brief description of the proposed

project and identify the principle

investigator, organizations actively

involved in the proposed project, and

the address and telephone number for

key contacts.

Applications

Your application will be evaluated on

the criteria listed, so it is important to

follow them in laying out your program

plan. The narrative should be no more

than 25 double-spaces, printed on one

side, with one inch margins and

unreduced font. The applicant should

provide a detailed description of

activities. In addition to the application

forms, the application must contain the

following in this order:

1. Table of Contents

A table of contents that provides page

numbers for each of the following

sections should be included.

2. Abstract

A one-page, single-spaced abstract

must be submitted with the application.

The heading should include the title of

the cooperative agreement, project title,

organization’s name and address, and

the principle investigator’s name and

telephone number. The abstract should

briefly summarize the program for

which funds are requested, the activities

to be undertaken, and the applicant’s

organizational structure. The abstract

must also contain a verification that the

total population of the communities to

be served will be between 300,000 and

700,000 people.

3. Project Narrative

The narrative must contain the

following sections:

a. Time-framed Objectives. Specific,

measurable, and time-framed objectives

should be developed based on the

project narrative. Creation of a two year

time-line for meeting these objectives is

expected.

b. Understanding of the medical and

psychological literature regarding

asthma control techniques and past

intervention attempts. Emphasis should

be placed on population-based methods

of asthma control.

c. A brief description of the

community or segment of city (or city as

a whole) identified as the population to

be served by this project. This should

include basic demographic, socioeconomic, and health information (i.e.,

number of primary care physicians,

asthma specialists, hospitals, public

clinics in these areas or accessible to the

people living in these areas).

d. Understanding of the asthma care

and control issues facing the community

selected to be served by this project.

Specific documentation of unmet needs,

such as the proportion of children

uninsured, measures of asthma

morbidity, and information on the

quality of asthma care, if available,

should be described here. Why these

Federal Register / Vol. 66, No. 111 / Friday, June 8, 2001 / Notices 30933

communities or areas of the city were

chosen for project inclusion should also

be briefly explained.

e. Collaboration within the

consortium. A description of the

important health care leaders and

institutions in your city and how and in

what way you plan to involve them in

the project activities must be included.

Using the list of potential collaborators

(See addendum 2, V) as a template, you

may wish to explain what role each of

these organizations play in the asthma

control plans of your city and why they

will or will not be included/emphasized

in the project. The expected financial

arrangements between applicant and

collaborators should be described here.

A letter from representatives of each of

the major collaborators in the

consortium describing how they plan to

actively participate and add to the

project should be included in the

application.

f. Initial intervention ideas. A

description of your initial intervention

ideas should be elaborated upon,

including their potential feasibility and

benefit in controlling asthma symptoms

or unscheduled visits.

g. Process of creating comprehensive

intervention strategies (including

protocols) from the initial intervention

ideas. The process conceived to take

place over the two year planning period

in order to be ready for the intervention

period should be described in this

section.

h. Plans for an evaluation of the two

year planning period (phase I). The

project evaluation should address the

experiences and lessons of such citywide collaboration efforts, community

assessment and information sharing,

protocol development, and other

planning phase activities. Evaluation

measures, whether quantitative or

qualitative, should be described.

i. A detailed plan to obtain a

comprehensive baseline assessment of

asthma-related morbidity and care

practices in the communities involved

in this project. A critical description of

how this baseline assessment will be

used to ultimately evaluate the

intervention activities of the project

(i.e., changes in population-based

measures of asthma morbidity, asthma

care, asthma education, access to

primary care, or other issues important

to asthma control addressed in the

intervention strategies) must be

included. Evaluation measures, whether

quantitative or qualitative, should be

described.

j. A description of those activities

conducted by the applicant and/or the

applicant’s organization related to, but

not supported by the cooperative

agreement.

4. Identification of Project Personnel

Include a biographical sketch (i.e.,

one page summary or abbreviated

curriculum vitae) for the principal

investigator and/or project coordinator

and other key personnel. Describe the

overall personnel capabilities of the

applicant’s organization in relation to

the potential project needs. To the

extent possible, list of all the proposed

project staff regardless of their funding

source. The list should include title,

qualifications, relevant experience,

percentage of time each will devote to

the project, as well as that portion of the

salary to be paid by the cooperative

agreement.

5. Facilities and Equipment

Describe the access and availability of

any facilities and equipment necessary

to carry out the planning phase project.

6. Budget and Budget Justification

Provide a detailed budget which

indicates the anticipated costs for

personnel, fringe benefits, travel,

supplies, contractual, consultants,

equipment, indirect and other items.

The required detailed budget is not

considered to be part of the program

narrative.

G. Application Submission and

Deadline

Submit the original and two copies of

PHS 5161–1 (OMB Number 0920–0428)

on or before August 10, 2001, to the

Grants Management Specialist

identified in the ‘‘Where to Obtain

Additional Information’’ section of this

announcement.

Deadline: Applications shall be

considered as meeting the deadline if

they are either:

1. Received on or before the deadline

date; or

2. Sent on or before the deadline date

and received in time for submission to

the independent review group.

(Applicants must request a legibly dated

U.S. Postal Service postmark or obtain

a legibly dated receipt from a

commercial carrier or U.S. Postal

Service. Private metered postmarks shall

not be acceptable as proof of timely

mailing.)

Late: Applications which do not meet

the criteria in 1. or 2. above will be

returned to the applicant.

H. Evaluation Criteria

Each application will be evaluated

individually against the following

criteria by an independent panel of

experts appointed by CDC:

1. Goals and Objectives: (10 percent)

The extent to which the applicant has

described a plan to make use of this two

year planning period. This should

include: Details in explaining how this

time period will be used to create or

strengthen a city-wide asthma

consortium, design and fine tune

effective intervention strategies, begin

efforts to improve quality of asthma care

locally, and initiate the processes of

community empowerment/change that

will be focused on.

2. Background: (10 percent)

The extent to which the proposal

addresses the critical evaluation of

existing asthma control literature, and

the identification of the asthma care

gaps and issues in the specific

communities designated to be the focus

of this intervention project will be

evaluated. Such an evaluation of the

asthma care gaps in the proposed

community could include the

proportion of children uninsured,

measures of asthma morbidity, and

information on the quality of asthma

care.

3. Asthma Control Intervention Ideas:

(20 percent)

a. The extent to which the application

describes a plan to improve asthma care

in the specific communities selected by

the applicant will be evaluated. This

includes how well conceived the

intervention concepts are in terms of

practicality, effectiveness (likelihood to

change asthma morbidity),

inclusiveness (whether all children with

asthma in the study area will have

access to the interventions),

comprehensiveness (providing multiple

ways to address asthma control

problems), originality, and level of

detail included in proposal (i.e.,

appropriate use of examples to

strengthen ideas in the proposal).

b. The extent to which the proposed

processes to improve and expand these

intervention ideas during the planning

phase are described.

4. Collaborative Effort: (25 percent)

The extent to which the applicant and

the consortium have the experience,

ability, and vision to succeed in an

effort to reduce the asthma burden in

the proposed community through the

participation of the most important and

influential health care and civic leaders

in the community. This includes the

specific ways in which the consortium

will operate, a history of successful

operation of the consortium in that city

or community, or other evidence that a

proposed collaboration would be

effective, and detailed plans to ensure

30934 Federal Register / Vol. 66, No. 111 / Friday, June 8, 2001 / Notices

active collaboration of all project

participants during the entire period of

this project.

5. Principal Investigator and Staff: (20

percent)

a. The extent to which the

qualifications and the proposed project

time allocation of the principal

investigator are described. A principal

investigator who has conducted,

evaluated, and published asthma

research in peer-reviewed journals, and

has specific authority and responsibility

to carry out the proposed project is

expected.

b. The extent to which a description

of additional staff to be assigned to this

project, their qualifications, the

proposed project time allocation, and

the role of the proposed staff is linked

to program objectives.

c. The extent to which the facilities

and other resources that would define

the applicant’s capacity to accomplish

the project are described.

6. Evaluation Plans: (15 percent)

The extent to which the applicant has

described a realistic and comprehensive

plan to accurately measure changes in

population-based asthma morbidity,

specific asthma care, asthma education

or other significant intervention

strategies over time using qualitative

and quantitative methods will be

scored. The ability of the applicant to

begin the baseline data collection during

the planning phase and to conduct a

process evaluation of the planning

period will be part of this evaluation

score.

7. Budget: (not scored)

The extent to which the budget is

clearly detailed, justified, and

appropriate for activities proposed.

I. Other Requirements

Technical Reporting Requirements

Provide CDC with original plus two

copies of:

1. Semi-annual progress reports.

2. Financial status report, no more

than 90 days after the end of the budget

period.

3. Final financial and performance

reports, no more than 90 days after the

end of the project period.

Send all reports to the Grants

Management Specialist identified in the

‘‘Where to Obtain Additional

Information’’ section of this

announcement.

The following additional

requirements are applicable to this

program. For a complete description of

each, see Attachment I in the

application kit.

AR–7 Executive Order 12372 Review

AR–8 Public Health System Reporting

Requirements

AR–9 Paperwork Reduction Act

Requirements

AR–10 Smoke-Free Workplace

Requirements

AR–11 Healthy People 2010

AR–12 Lobbying Restrictions

AR–14 Accounting System

Requirements

AR–15 Proof of Non-Profit Status

J. Authority and Catalog of Federal

Domestic Assistance Number

This program is authorized under

section 301 of the Public Health Service

Act, [42 U.S.C. section 241 and 247b],

as amended. The Catalog of Federal

Domestic Assistance number is 93.283.

K. Where to Obtain Additional

Information

This and other CDC announcements

can be found on the CDC home page

Internet address—http://www.cdc.gov

Click on ‘‘Funding’’ then ‘‘Grants and

Cooperative Agreements.’’

To receive additional written

information and to request an

application kit, call 1–888–GRANTS4

(1–888–472–6874). You will be asked to

leave your name and address and will

be instructed to identify the Program

Announcement number of interest.

If you have questions after reviewing

the contents of all the documents,

business management technical

assistance may be obtained from: Sonia

Rowell, Grants Management Specialist,

Grants Management Branch,

Procurement and Grants Office, Centers

for Disease Control and Prevention,

2920 Brandywine Road, Room 3000, MS

E–13, Atlanta, GA 30341–4146.

Telephone number: 770–488–2724,

Email address: svp1@cdc.gov.

For program technical assistance,

contact: Michael Friedman, M.D., Air

Pollution and Respiratory Health

Branch, National Center for

Environmental Health, Centers for

Disease Control and Prevention, 1600

Clifton Road, NE., MS E–17, Atlanta,

Georgia 30333, Telephone number: 404–

639–2520, Email address: mff7@cdc.gov.

Signed: June 4, 2001.

John L. Williams,

Director, Procurement and Grants Office,

Centers for Disease Control and Prevention

(CDC).

[FR Doc. 01–14447 Filed 6–7–01; 8:45 am]

BILLING CODE 4163–18–P

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

Centers for Disease Control and

Prevention

Advisory Committee to the Director,

Centers for Disease Control and

Prevention: Meeting

In accordance with section 10(a)(2) of

the Federal Advisory Committee Act

(Pub. L. 92–463), the Centers for Disease

Control and Prevention (CDC)

announces the following Advisory

Committee meeting.

Name: Advisory Committee to the Director,

CDC.

Time and Date: 8:30 a.m.–4 p.m., July 13,

2001.

Place: The Sheraton Colony Square Hotel,

188 14th Street, NE., Atlanta, Georgia 30361.

Status: Open to the public, limited only by

the space available. The meeting room

accommodates approximately 50 people.

Purpose: The committee will anticipate,

identify, and propose solutions to strategic

and broad issues facing CDC.

Matters to be Discussed: Agenda items will

include updates from Dr. Jeffrey P. Koplan,

M.D., M.P.H., Director, CDC regarding the

current CDC Director’s priorities with

discussions of program activities including

updates on CDC scientific and programmatic

activities.

Agenda items are subject to change as

priorities dictate.

Contact Person for More Information:

Kathy Cahill, Executive Secretary, Advisory

Committee to the Director, CDC, 1600 Clifton

Road, NE, M/S D–24, Atlanta, Georgia 30333.

Telephone 404/639–7060.

The Director, Management Analysis and

Services Office, has been delegated the

authority to sign Federal Register notices

pertaining to announcements of meetings and

other committee management activities, for

both the Centers for Disease Control and

Prevention and the Agency for Toxic

Substances and Disease Registry.

Dated: June 4, 2001.

John Burckhardt,

Acting Director, Management Analysis and

Services Office, Centers for Disease Control

and Prevention.

[FR Doc. 01–14449 Filed 6–7–01; 8:45 am]

BILLING CODE 4163–18–P

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

Centers for Disease Control and

Prevention

Notice of Meeting; Office of the

Director, Centers for Disease Control

and Prevention (CDC), Announces the

Following Meeting

NAME: Guide to Community Preventive

Services (GCPS) Task Force Meeting.